IDXX Idexx Laboratories
Intrinsic value$142.25
Price (at call)$506.53
Margin of safety
-71.9%
vs market (rating basis)
-30.0%
Model unavailable; showing baseline valuation.
⚠ LLM error: unbalanced JSON in response: '{\n "story": "IDEXX dominates companion-animal diagnostics with a large installed instrument base and ~80% recurring consumables and services revenue, a classic razor/razorblade moat.'; using baseline
The story
Value drivers
| Revenue growth (Y1) | 8.5% |
| Terminal growth | 3.5% |
| Forecast horizon | 10y |
| Target operating margin | 21.1% |
| Years to target margin | 5 |
| Sales-to-capital | 1.86 |
| Beta | 1.54 |
| Failure probability | 0.0% |
| Cost of capital (WACC) | 11.7% |
| Terminal WACC | 9.4% |
Valuation bridge
| PV of explicit FCFF | 5.69B |
| PV of terminal value | 6.19B |
| Equity value | 11.21B |
| ÷ shares → per share | $142.25 |
News
bearish -0.30 · 8 articles
- Pfizer Stock Or Zoetis: Is The Comeback Worth Paying Up For?
- Insider Alert: IDEXX Director Lawrence Kingsley Sells $1.2 Million of Stock
- Is IDEXX Laboratories Stock Underperforming the Dow?
- Idexx (IDXX) Down 7.8% Since Last Earnings Report: Can It Rebound?
- Are Wall Street Analysts Predicting IDEXX Laboratories Stock Will Climb or Sink?
- Is it a Prudent Move to Retain IDEXX Stock in Your Portfolio Now?
- Rationale Behind Baron Focused Growth Fund’s IDEXX Laboratories (IDXX) Holding
- IDXX Raises 2026 EPS Outlook as Diagnostic Growth and Margins Improve
Projected free cash flow to the firm
| Yr | Revenue | Growth | Margin | NOPAT | Reinvest | FCFF | PV |
|---|---|---|---|---|---|---|---|
| 1 | 4.94B | 8.5% | 29.9% | 1.18B | 209.07M | 973.10M | 870.97M |
| 2 | 5.33B | 8.0% | 27.7% | 1.18B | 212.03M | 969.90M | 777.00M |
| 3 | 5.73B | 7.4% | 25.5% | 1.17B | 212.88M | 955.21M | 684.92M |
| 4 | 6.12B | 6.8% | 23.3% | 1.14B | 211.42M | 928.34M | 595.80M |
| 5 | 6.51B | 6.3% | 21.1% | 1.10B | 207.49M | 888.83M | 510.57M |
| 6 | 6.88B | 5.7% | 21.1% | 1.16B | 200.98M | 958.19M | 492.65M |
| 7 | 7.24B | 5.2% | 21.1% | 1.22B | 191.81M | 1.03B | 472.76M |
| 8 | 7.57B | 4.6% | 21.1% | 1.28B | 179.98M | 1.10B | 451.20M |
| 9 | 7.88B | 4.1% | 21.1% | 1.33B | 165.52M | 1.16B | 428.25M |
| 10 | 8.15B | 3.5% | 21.1% | 1.37B | 148.55M | 1.23B | 404.24M |